Skip to main navigation Skip to search Skip to main content

Featured updates to the NCCN guidelines: Kidney Cancer, Version 2.2020

  • Robert J. Motzer
  • , Eric Jonasch
  • , M. Dror Michaelson
  • , Lakshminarayanan Nandagopal
  • , John L. Gore
  • , Saby George
  • , Ajjai Alva
  • , Naomi Haas
  • , Michael R. Harrison
  • , Elizabeth R. Plimack
  • , Jeffrey Sosman
  • , Neeraj Agarwal
  • , Sam Bhayani
  • , Toni K. Choueiri
  • , Brian A. Costello
  • , Ithaar H. Derweesh
  • , Thomas H. Gallagher
  • , Steven L. Hancock
  • , Christos Kyriakopoulos
  • , Chad LaGrange
  • Elaine T. Lam, Clayton Lau, Bryan Lewis, Brandon Manley, Brittany McCreery, Andrew McDonald, Amir Mortazavi, Phillip M. Pierorazio, Lee Ponsky, Bruce G. Redman, Bradley Somer, Geoffrey Wile, Mary A. Dwyer, Lydia J. Hammond, Griselda Zuccarino-Catania
  • Memorial Sloan-Kettering Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Massachusetts General Hospital
  • Seattle Cancer Care Alliance
  • University of Michigan, Ann Arbor
  • University of Pennsylvania
  • Northwestern University
  • University of Utah
  • Washington University St. Louis
  • Cancer Center
  • Mayo Clinic
  • University of California at San Diego
  • Stanford University
  • University of Wisconsin-Madison
  • University of Nebraska Medical Center
  • University of Colorado Boulder
  • Ohio State University
  • Case Western Reserve University
  • University of Tennessee Health Science Center
  • Vander-bilt- Ingram Cancer Center
  • National Comprehensive Cancer Network

Research output: Contribution to journalReview articlepeer-review

201 Scopus citations

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

Original languageEnglish
Pages (from-to)1278-1285
Number of pages8
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume17
Issue number11
DOIs
StatePublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Featured updates to the NCCN guidelines: Kidney Cancer, Version 2.2020'. Together they form a unique fingerprint.

Cite this